Literature DB >> 32042504

A unique case of cabergoline-induced reversible cerebral vasoconstriction.

Orly Moshe-Lilie1, Parker Miller1, Michael Lane1.   

Abstract

Entities:  

Year:  2019        PMID： 32042504      PMCID： PMC6927447          DOI： 10.1212/CPJ.0000000000000620

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  7 in total

Review 1.  Reversible cerebral segmental vasoconstriction.

Authors:  G K Call; M C Fleming; S Sealfon; H Levine; J P Kistler; C M Fisher
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

Review 2.  Reversible cerebral vasoconstriction syndrome: a review of recent research.

Authors:  Arnaldo Velez; James S McKinney
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

3.  Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. III. Agonist and antagonist properties at serotonin, 5-HT(1) and 5-HT(2), receptor subtypes.

Authors:  Adrian Newman-Tancredi; Didier Cussac; Yann Quentric; Manuelle Touzard; Laurence Verrièle; Nathalie Carpentier; Mark J Millan
Journal:  J Pharmacol Exp Ther       Date:  2002-11       Impact factor: 4.030

Review 4.  Systematic review of reversible cerebral vasoconstriction syndrome.

Authors:  Ahsan Sattar; Georgios Manousakis; Matthew B Jensen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-10

Review 5.  Reversible Cerebral Vasoconstriction Syndrome, Part 2: Diagnostic Work-Up, Imaging Evaluation, and Differential Diagnosis.

Authors:  T R Miller; R Shivashankar; M Mossa-Basha; D Gandhi
Journal:  AJNR Am J Neuroradiol       Date:  2015-01-22       Impact factor: 3.825

6.  Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu; Joshua W Fok; Oguzhan Kursun; Raul G Nogueira; Matthew P Frosch; Verne S Caviness
Journal:  Ann Neurol       Date:  2016-04-28       Impact factor: 10.422

Review 7.  Primary angiitis of the central nervous system and reversible cerebral vasoconstriction syndrome.

Authors:  Tariq A Hammad; Rula A Hajj-Ali
Journal:  Curr Atheroscler Rep       Date:  2013-08       Impact factor: 5.967
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.